Follow The Filings

ZBH Zimmer Biomet

Zimmer Biomet earnings company data as of 7:06 PM ET 10/30

  • 0 of 1 EPS beats
  • 1 Owner
  • Rank #121
  • Max 0.0%
  • Master 0.19%

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 1.89 — —
Rev $2.04B — —
FY2026 Q2 5 Aug EPS 2.01 1.03 Miss -48.8%
Rev — — —

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

All holders
  1. Kentucky Trust Co. 0.03%

Insider trades

Open-market buys and sales by ZBH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZBH insider trades
  • None no insider bought on the open market
  • $1.6M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kevin R Thornal Grp Pres-Global Business
    Sale
    $529K 5,691 shares at $92.95 100% of stake
    Traded Sep 11 Filed Sep 15
    ↗
  2. Chad F Phipps See remarks below.
    Sale
    $295K 3,000 shares at $98.35 4.4% of stake
    Traded Sep 4 Filed Sep 9
    ↗
  3. Sang Yi Group President, Asia Pacific
    Sale
    $413K 5,000 shares at $82.64 16% of stake
    Traded May 29 Filed Jun 2
    ↗
  4. Lori Winkler SVP and CHRO
    Sale
    $251K 2,650 shares at $94.66 21% of stake
    Traded Mar 12 Filed Mar 16
    ↗
  5. Sang Yi Group President, Asia Pacific
    Sale
    $96K 1,000 shares at $96.49 5.4% of stake
    Traded Feb 12 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 option exercises and 32 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.